TriSalus Life Sciences receives FDA clearance for TriNav Advance device

Go back to TriSalus Life Sciences receives FDA clearance for TriNav Advance device
(NASDAQ: TLSI) Delayed: 3.72 +0.19 (5.38%)
Previous Close $3.53    52 Week High $ 
Open $3.57    52 Week Low $ 
Day High $3.72    P/E N/A 
Day Low $3.57    EPS $ 
Volume 57,702